Could a pill improve sleep and thinking in kids with down syndrome?
NCT ID NCT05933603
First seen Apr 08, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tests a combination of two drugs (atomoxetine and oxybutynin) given at bedtime to children with Down syndrome who have obstructive sleep apnea. The goal is to see if the treatment improves breathing during sleep and thinking skills. Thirty-six children aged 6 to 17 will take the medication for 6 months and have sleep tests and cognitive assessments before and after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arizona
Tucson, Arizona, 86721, United States
Conditions
Explore the condition pages connected to this study.